A Leukemia Drug for Parkinson's?

]]>(MedPage Today) -- The chronic myeloid leukemia drug nilotinib (Tasigna) altered biomarkers in patients with moderately severe Parkinson's disease in a way suggesting potential for treating the condition, researchers for a single-center phase II...